Abstract:
The invention relates to a confectionery product comprising an extruded body portion, the body portion having a plurality of capillaries disposed therein, one or more of the capillaries being at least partially filled with a fill material which is a different material from that of the extruded body portion, the fill material and optionally the body portion comprising various active and/or reactive components. Some embodiments are designed to provide sequential release profiles. The invention also relates to a process for the manufacture of the same.
Abstract:
The present invention relates to a confectionery product comprising an extruded body portion, the body portion being formed from a material which is liquid during extrusion and which has a plurality of capillaries disposed therein, the capillaries having an average width or diameter of no more than 3 millimetres. The invention also relates to a process of manufacturing the same.
Abstract:
The present invention relates to a consumable biscuit product comprising an extruded biscuit portion, the body portion being formed with one or more channels disposed therein, wherein the one or more channels contain a substance which is different from the substance of the body portion and wherein at least one of the channels does not extend along the full length of the body portion. The present invention also provides a method of production of the same.
Abstract:
The present invention provides methods and compositions for recombinant protein production through replication-defective adenoviral vector infection of non-trans- complementation cell lines. Thus, this invention describes methods of heterologous protein production without an accompanied production of adenoviral vectors.
Abstract:
The present invention relates to improved methods for producing adenovirus compositions wherein host cells are grown in a bioreactor and purified by size partitioning purification to provide purified adenovirus compositions.
Abstract:
A system is provided for routing and managing service requests. A service request is received from a service requestor (100), and a determination (160) is made as to which of a plurality of service-providing nodes the service request should be transmitted. The service request is transmitted to the determined service-providing node. The service request may comprise one or more attributes describing the service request, and the determination as to which of the service-providing nodes the service request is transmitted may be based on the value of the one or more service request attributes (120). The service request may be divided into portions, each portion transmitted to a service-providing node. Information received from a service-providing node may enable an evaluation of whether and why a service request was not fulfilled.
Abstract:
Embodiments of the present invention include the construction and generation of a multi-use adenoviral vaccine platform applicable to biodefense, and emerging and re- emerging infectious diseases. Adenoviral vaccines of the invention will elicit an immune response against pathogenic organisms that cause such infectious diseases. In certain aspects of the invention, the pathogenic organisms include, but are not limited to EEEV and Y. pestis. Further embodiments of the invention include compositions and methods related to such adenoviral vaccines.
Abstract:
Compositions and methods for preventing or inhibiting the growth of a hyperproliferative lesion in a subject that include a nucleic acid comprised in a solid or semi¬ solid formation or in a transdermal or transcutaneous delivery device are disclosed. Also disclosed are compositions of a nucleic acid capable of preventing or inhibiting the growth of a hyperproliferative lesion in a subject that include an adhesive. Compositions of a nucleic acid capable of preventing or inhibiting the growth of a hyperproliferative lesion in a subject that include a nucleic acid uptake enhancer are also disclosed. Methods of preventing or inhibiting the growth of a hyperproliferative lesion in a subject that involve these therapeutic compositions and devices are also disclosed.
Abstract:
The present invention relates to compositions comprising and methods for producing adenovirus compositions wherein host cells are grown in a bioreactor and purified by size partitioning purification to provide purified adenovirus compositions.